DS process characterization
Ended Awarded Last action
- Contract number
- W911SR22F0073
- Awardee
-
Resilience Government Services, Inc. UEI GC2RFAZK8G64
- Awarding agency
-
ACC Aberdeen Proving Ground
Army Contracting Command, Department of Defense
- Obligated
- $4,459,366
Award facts
- Opportunity
-
- W911SR22R0040 Solicitation number
- Contract value 92% obligated
-
- $4,459,366.48 Current, with exercised options
- $4,861,155.86 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Joint PEO Chemical and Biological Defense Acquisition Support Center, Department of Defense
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Not Available for Competition Only One Source
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Santa Fe, FL 32615, USA
- Legislative mandates
-
- Walsh-Healey Public Contracts Act FAR subpart 22.6
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Default | $0 | |
| Funding Only Action | -$26,789 | |
| Other Administrative Action | $0 | |
| Funding Only Action | -$375,000 | |
| Funding Only Action | $0 | |
| Supplemental Agreement for work within scope | $999,909 | |
| Other Administrative Action | $1,100,000 | |
| Other Administrative Action | -$1,656,275 | |
| Supplemental Agreement for work within scope | $2,000,000 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $2,417,522 |
Show all 11
About this award
Resilience Government Services, Inc. (doing business as Nanotherapeutics Inc.) was awarded a $4.86 million delivery order by the Department of Defense's Joint Program Executive Office for Chemical and Biological Defense to conduct research and development activities for a monoclonal antibody countermeasure against botulinum neurotoxin. The contract is structured as a cost-plus-fixed-fee delivery order with work to be performed in Alachua, Florida, and is scheduled for completion by February 28, 2025. The award was issued on June 16, 2022, with no set-aside designation applied.
This delivery order represents a component of Resilience's broader engagement with the Department of Defense on medical countermeasure development. The contractor currently holds a $249 million single-award Indefinite Delivery Contract with the Army Acquisition Support Center that serves as the primary acquisition vehicle for FDA-approved products supporting chemical and biological defense initiatives. Resilience specializes in biomanufacturing and process development for complex medicines, with demonstrated experience advancing countermeasures through clinical trials and regulatory approval processes aimed at achieving FDA licensure for biological threat mitigation.
Quick answers
Who was awarded contract W911SR22F0073?
W911SR22F0073 was awarded to Resilience Government Services, Inc. by ACC Aberdeen Proving Ground (Army Contracting Command) on June 16, 2022.
How much is contract W911SR22F0073 worth?
The government has obligated $4,459,366 on W911SR22F0073. Its potential value, with all options, is $4,861,156.
Which agency awarded contract W911SR22F0073?
ACC Aberdeen Proving Ground (Army Contracting Command) awarded W911SR22F0073, with funding from Joint PEO Chemical and Biological Defense (Acquisition Support Center).
Is contract W911SR22F0073 an order under another contract?
Yes. W911SR22F0073 is a delivery order under W911SR22D0009, an indefinite delivery contract.
Was contract W911SR22F0073 competed?
The extent of competition for W911SR22F0073 was not available for competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award